Images showing body composition have shown that where body fat is stored is more of a factor in cardiovascular and metabolic risks than the type of fat.
Where fat is stored in the body may play a bigger role in heart attack, stroke, and diabetes risk than the amount of fat overall, according to two studies presented at RSNA.
In the first study, researchers from the United States studied 200 women and men to determine if there were sex-differences in body composition and ectopic fat depots and whether these may be associated with a sex-specific cardiometabolic risk profile.
Ninety-one men and 109 women (mean age 37) participated in the trial. All were non-diabetic and overweight or obese (mean BMI: 35.2±5.8 kg/m2) but were otherwise healthy. After an overnight fast, the subjects underwent DXA and CT for body composition, 1H-MRS at 3T of soleus muscle for intramyocellular (IMCL), and right hepatic lobe for intrahepatic lipids (IHL) quantification, serum glucose, insulin and lipids. Men and women were compared by ANOVA. Linear regression analyses between body composition measures and cardiometabolic risk markers were performed.
“We hypothesized that there are gender-based differences in body composition and ectopic fat depots and that these could be associated with gender-specific risk profiles for diseases like diabetes, heart disease and stroke,” lead author Miriam A. Bredella, MD, a radiologist at Massachusetts General Hospital and associate professor of radiology at Harvard Medical School in Boston, said in a release.
The results showed while the women and men were of similar age and BMI, the women had higher %fat mass by DXA and lower lean mass compared with the men. However, the men had more visceral adipose tissue (VAT) and VAT/abdominal subcutaneous adipose tissue (SAT), resulting in the “beer belly.” They also had more muscle mass, IMCL, and IHL, while the women had more femoral SAT. Compared to the women, the men had higher measures of cardiometabolic risk, including serum triglycerides, apolipoprotein B, fasting insulin and HOMA-IR. However, in women, VAT, IMCL, and IHL were strongly associated with these measures of cardiometabolic risk while in men these associations were weaker or non-significant.
In the second study, researchers recruited 188 subjects to determine if relative sarcopenia was associated with cardiometabolic risk markers in young adults with obesity.
One-hundred women and 88 men (mean age 36.8) participated in the study. They had a mean BMI of 35.0±5.7 kg/m2. All subjects underwent DXA and CT for body composition, an oral glucose tolerance test (OGTT), fasting serum insulin, lipids, and inflammatory markers. DXA appendicular lean mass (ALM)/BMI was used as a measure of relative sarcopenia and subjects were divided by the ALM/BMI median. Groups were compared by ANOVA.
The results showed that although they were of similar age and weight, women with lower ALM/BMI (relative sarcopenia) had a higher mean 120-minute glucose level and higher glucose area under the curve on OGTT, lower HDL cholesterol, higher apolipoproteinB (ApoB) and ApoB/LDL, higher hsCRP and fibrinogen and lower muscle attenuation, suggestive of fatty infiltration compared to women with higher ALM/BMI. Again, despite being of similar age and weight, men with lower ALM/BMI had higher mean insulin, HOMA-IR, hsCRP, and fibrinogen, and lower muscle attenuation compared to men with higher ALM/BMI.
“Sarcopenic obesity may be an under-appreciated mechanism linking obesity to cardiometabolic disease,” Bredella explained. “That stresses the importance of building up muscle mass in the setting of obesity.”
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Study Shows Benefits of AI in Detecting Lung Cancer Risk in Non-Smokers
November 22nd 2023Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
Could an Emerging AI System Lead to Earlier Autism Detection with DT-MRI?
November 21st 2023Through assessment of diffusion tensor MRI of the brain, a new AI system reportedly offers a 97 percent sensitivity rate in diagnosing autism in children between two to four years of age, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.